APGE Stock Analysis: Buy, Sell, or Hold?
APGE - Apogee Therapeutics, Inc. Common Stock
$132.91
0.14 (0.11%)
▲
5d:
+0.17%
30d:
+68.86%
90d:
+57.78%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.0/10
Get Alerted When APGE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: APGE is 7.6% above its trading range ($123.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: APGE is 7.6% above its trading range ($123.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: APGE is currently trading at $132.91, which is considered extended relative to its 30-day fair value range of $77.49 to $123.52.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is approaching resistance at $133.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: APGE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, APGE is in a strong uptrend. The price is approaching resistance at $133.85. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: APGE has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$77.49 -
$123.52
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
APGE is technically overbought (RSI 81). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($130.53)
Trading Range Analysis
30-Day Trading Range
$77.49 -
$123.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$87.40
Resistance Level
$133.85
Current Trend
Strong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.62
Wall Street Target
$130.53
(-1.8%)
Share & Embed Analysis
Last updated: July 03, 2026 12:42 AM ET
Data refreshes hourly during market hours. Next update: 1:42 AM
Data refreshes hourly during market hours. Next update: 1:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APGE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Thomas Henderson
SELL
20000 shares
2026-04-08
Carl Dambkowski
SELL
5500 shares
2026-04-01
Michael Thomas Henderson
SELL
20000 shares
2026-03-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 63 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1041 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
Advanced APGE Option Strategies
Professional options setups generated by AI based on today's APGE price and gamma walls.
